Literature DB >> 23988897

Oral administration of benzyl-isothiocyanate inhibits in vivo growth of subcutaneous xenograft tumors of human malignant melanoma A375.S2 cells.

Wei-Ya Ni1, Yu-Ping Hsiao, Shu-Chun Hsu, Shu-Ching Hsueh, Chuan-Hsun Chang, Bin-Chuan Ji, Jai-Sing Yang, Hsu-Feng Lu, Jing-Gung Chung.   

Abstract

A number of experiments have demonstrated that benzyl-isothiocyanate (BITC) induces cytotoxic cell death through the induction of apoptosis in various human cancer cell lines. In the present study, we investigated the effects of BITC on the growth of A375.S2 cell xenograft tumors in nude BALB/c mice in vivo. The A375.S2 cancer cells were inoculated subcutaneously into the lower flanks of each nude mouse. After cancer cell inoculation, all animals were maintained in the animal room for seven days and all mice produced one palpable tumor. Animals were randomly divided into two groups, each mouse was individually given intraperitoneal injections of BITC (20 mg/kg) or not (control). Results from the in vivo experiments indicated that BITC did not significantly affect the body weight of nude BALB/c mice bearing xenograft A375.S2 cell tumors but did significantly decrease the tumor weight.

Entities:  

Keywords:  A375.S2 melanoma cells; BITC; in vivo; nude mice

Mesh:

Substances:

Year:  2013        PMID: 23988897

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  6 in total

1.  Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.

Authors:  Ravi Prakash Sahu
Journal:  Mol Med Rep       Date:  2015-02-18       Impact factor: 2.952

2.  Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest.

Authors:  Han Jin Cho; Do Young Lim; Gyoo Taik Kwon; Ji Hee Kim; Zunnan Huang; Hyerim Song; Yoon Sin Oh; Young-Hee Kang; Ki Won Lee; Zigang Dong; Jung Han Yoon Park
Journal:  Int J Mol Sci       Date:  2016-02-22       Impact factor: 5.923

3.  Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β‑catenin pathway.

Authors:  Bei Xie; Lei Zhao; Lanlan Guo; Hang Liu; Siyu Fu; Wenjuan Fan; Li Lin; Jing Chen; Bei Wang; Linlan Fan; Hulai Wei
Journal:  Mol Med Rep       Date:  2019-06-18       Impact factor: 3.423

4.  Allyl isothiocyanate regulates lysine acetylation and methylation marks in an experimental model of malignant melanoma.

Authors:  Melina Mitsiogianni; Theodora Mantso; Dimitrios T Trafalis; H P Vasantha Rupasinghe; Vasilis Zoumpourlis; Rodrigo Franco; Sotiris Botaitis; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Eur J Nutr       Date:  2019-02-14       Impact factor: 5.614

5.  Benzyl Isothiocyanate Induces Apoptosis via Reactive Oxygen Species-Initiated Mitochondrial Dysfunction and DR4 and DR5 Death Receptor Activation in Gastric Adenocarcinoma Cells.

Authors:  Khin Wah Wah Han; Wah Wah Po; Uy Dong Sohn; Hyun-Jung Kim
Journal:  Biomolecules       Date:  2019-12-06

6.  Benzyl isothiocyanate (BITC) triggers mitochondria-mediated apoptotic machinery in human cisplatin-resistant oral cancer CAR cells.

Authors:  Chiu-Fang Lee; Ni-Na Chiang; Yao-Hua Lu; Yu-Syuan Huang; Jai-Sing Yang; Shih-Chang Tsai; Chi-Cheng Lu; Fu-An Chen
Journal:  Biomedicine (Taipei)       Date:  2018-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.